| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 01/22/2004 | US20040014979 For use as antitumor agents |
| 01/22/2004 | US20040014978 Such as (4S,7R,8S,9S,13(Z),16S(Z))-4,8-Dihydroxy-16-(1-fluoro-2-(2-methyl-4 -thiazolyl)ethenyl)-1-oxa-5,5,7,9,13-pentamethyl-cyclohexadec-13-ene-2,6 -dione |
| 01/22/2004 | US20040014967 Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound |
| 01/22/2004 | US20040014890 Cycloaliphatic epoxy compounds containing styrenic, cinnamyl, or maleimide functionality |
| 01/22/2004 | US20040014802 Aminoindazole derivatives and intermediates, preparation thereof, and pharmaceutical compositions thereof |
| 01/22/2004 | US20040014788 Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht receptor agonists |
| 01/22/2004 | US20040014787 Hormone inhibitors; controlling fertility |
| 01/22/2004 | US20040014783 Antiinflammatory agents; autoimmune diseases; rheumatic diseases; anticholesterol agents; cardiovascular disorders |
| 01/22/2004 | US20040014776 Anticancer agents; cyclin-dependent kinase inhibitor |
| 01/22/2004 | US20040014775 2,5-substituted pyrimidine derivatives-CCR-3 receptor antagonists |
| 01/22/2004 | US20040014774 Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase |
| 01/22/2004 | US20040014768 Psychological disorders; schizophrenia |
| 01/22/2004 | US20040014767 Central nervous system diosrders; antidepressants, anxiolytic agents, anxiolytic agents |
| 01/22/2004 | US20040014765 Chk-1 inhibitors |
| 01/22/2004 | US20040014758 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 01/22/2004 | US20040014757 Method for the treatment or prevention of viral infection using nucleoside analogues |
| 01/22/2004 | US20040014744 Anticancer, antitumor agents |
| 01/22/2004 | US20040014392 Heat resistance |
| 01/22/2004 | DE10231711A1 Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Bicyclic heterocycles, pharmaceutical compositions containing them, their use and process for their preparation |
| 01/22/2004 | DE10228857A1 Tetraetherlipide mit kleinen Kopfgruppen, deren Herstellung und Verwendung Tetraether lipids with small head groups, their preparation and use |
| 01/22/2004 | DE10228132A1 Amide cyclischer Aminosäuren als PDE 4 Inhibitoren Amides of cyclic amino acids as PDE 4 inhibitors |
| 01/22/2004 | CA2492164A1 Substituted benzylamine derivatives and methods of use |
| 01/22/2004 | CA2492100A1 Substituted 2-alkylamine nicotinic amide derivatives and use there of |
| 01/22/2004 | CA2492045A1 Substituted amine derivatives and methods of use |
| 01/22/2004 | CA2491422A1 Novel macrocycles for the treatment of cancer diseases |
| 01/22/2004 | CA2491213A1 Cck-1 receptor modulators |
| 01/22/2004 | CA2491191A1 Receptor-type kinase modulators and methods of use |
| 01/21/2004 | EP1382603A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF |
| 01/21/2004 | EP1382598A1 Novel heterocyclic derivatives |
| 01/21/2004 | EP1382597A2 Steroid receptor modulator compounds and methods |
| 01/21/2004 | EP1382332A1 Method for inhibiting bacterial or fungal growth using a polyamine derivative as complexing agent |
| 01/21/2004 | EP1381602A1 Heterocyclyldicarbamides as caspase inhibitors |
| 01/21/2004 | EP1381600A1 Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-benzodioxan |
| 01/21/2004 | EP1381599A1 Quinazoline derivatives |
| 01/21/2004 | EP1381598A1 Novel tyrosine kinase inhibitors |
| 01/21/2004 | EP1381592A1 1,4-disubstituted benzo-fused compounds |
| 01/21/2004 | EP1381590A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 01/21/2004 | EP1381382A2 Methods and compositions for the treatment of diseases of the eye |
| 01/21/2004 | EP1381366A2 Indole, azaindole and related heterocyclic amidopiperazine derivatives |
| 01/21/2004 | EP1381359A1 Aurones as telomerase inhibitors |
| 01/21/2004 | EP1305028A4 Antimicrobial biaryl compounds |
| 01/21/2004 | EP1280799B1 Ortho-substituted anthranilic acid amides and their use as medicaments |
| 01/21/2004 | EP0937048B1 HETEROCYCLE DERIVATIVES WHICH INHIBIT FACTOR Xa |
| 01/21/2004 | EP0811002B1 Benzylpiperidines and piperazines as muscarinic antagonists |
| 01/21/2004 | CN1469875A Pyrazole compounds useful as protein kinase inhibitors |
| 01/21/2004 | CN1469874A Pyrazole compounds useful as protein kinase inhibitors |
| 01/21/2004 | CN1469873A Piperidine compounds as anti-allergic |
| 01/21/2004 | CN1469870A A process for the preparation of bis-benzazolyl compounds |
| 01/21/2004 | CN1469866A New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl- pyrimidines, their preparation and application as medication |
| 01/21/2004 | CN1469743A 雌激素受体调节剂 Estrogen receptor modulators |
| 01/21/2004 | CN1135236C 5-membered ring heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists |
| 01/21/2004 | CN1135229C Water soluble azoles as broad-spectrum antifungals |
| 01/21/2004 | CN1135227C 2,6-twice substituted pyridine and 2,4 twice substituted pyrimidine for berbicide |
| 01/21/2004 | CN1135224C Benzimidazole derivatives |
| 01/20/2004 | US6680335 Methods of modulating protein tyrosine kinase function with substituted indolinone compounds |
| 01/20/2004 | US6680330 Rapamycin dialdehydes |
| 01/20/2004 | US6680321 4-((1-piperazinylmethyl)-benzamide derivatives; hypotensive agents; immunomodulators |
| 01/20/2004 | US6680318 Piperazinomethylbenzamides as delta-opioid receptor agonists |
| 01/20/2004 | US6680315 Compounds that down-regulate interleukin-12 production used for treating inflammatory diseases: rheumatoid arthritis, sepsis, chrohn's disease, multiple sclerosis, psoriasis or insulin-dependent diabetes |
| 01/20/2004 | US6680312 Sulfonamide derivatives, their production and use |
| 01/20/2004 | US6680303 3′,5-difluoro-2′,3′-didehydropyrimidine nucleosides and methods of treatment therewith |
| 01/20/2004 | CA2303498C Dioxocyclopentyl hydroxamic acids |
| 01/20/2004 | CA2274621C New nitrone derivatives, their preparation method and pharmaceutical compositions comprising them |
| 01/20/2004 | CA2174104C Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 01/15/2004 | WO2004005472A2 Inhibitors of ftsz and uses thereof |
| 01/15/2004 | WO2004005284A1 Substituted 3-cyanoquinolines as mek inhibitors |
| 01/15/2004 | WO2004005283A1 Imidazoles, oxazoles and thiazoles with protein kinase inhibiting activities |
| 01/15/2004 | WO2004005281A1 Inhibitors of tyrosine kinases |
| 01/15/2004 | WO2004005279A2 Substituted anthranilic amide derivatives and methods of use |
| 01/15/2004 | WO2004005276A1 Process for preparation of 1,3-benzodioxole-2-spiro- cycloalkane derivatives |
| 01/15/2004 | WO2004005265A1 Quinazoline derivatives |
| 01/15/2004 | WO2004005264A2 Imidazole compounds for the treatment of hepatitis c virus infections |
| 01/15/2004 | WO2004005253A1 Indolin phenylsulfonamide derivatives |
| 01/15/2004 | WO2004005252A1 Azabicyclo derivatives as muscarinic receptor antagonists |
| 01/15/2004 | WO2004004732A1 Quinazoline derivatives for use in the treatment of cancer |
| 01/15/2004 | WO2004004731A1 2, 5-substituted pyrimidine derivatives as ccr-3 receptor antagonists ix |
| 01/15/2004 | WO2004004730A2 2-aminopyrazine derivatives as inhibitors of cyclin dependent kinases for the treatment of proliferative disorders |
| 01/15/2004 | WO2004004727A1 3,4-dihydroisoquinolin-1-one derivatives as inducers of apoptosis |
| 01/15/2004 | WO2004004726A1 Mchir antagonists |
| 01/15/2004 | WO2004004722A1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(nk-1) antagonists for the treatment of emesis, depression, anxiety and cough |
| 01/15/2004 | WO2004004720A1 3-`(hetero) arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors |
| 01/15/2004 | WO2004004715A2 Novel delta opioid receptor ligands |
| 01/15/2004 | WO2004004699A2 Use of dantrolene, a ryanodine antagonist, in treating neural injury |
| 01/15/2004 | WO2004004657A2 Hiv integrase inhibitors |
| 01/15/2004 | WO2004004632A2 Flavone derivatives as inhibitors of cyclin-dependent kinases |
| 01/15/2004 | WO2004004629A2 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
| 01/15/2004 | WO2003092608A3 Methionine aminopeptidase-2 inhibitors and methods of use thereof |
| 01/15/2004 | WO2003091247A3 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 01/15/2004 | WO2003066060A3 Use of tyrosine kinase inhibitors for the treatment of inflammatory processes |
| 01/15/2004 | WO2002055025A3 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection |
| 01/15/2004 | US20040010148 Antiinflammatory agents, antiallergens, antiproliferative agents, immunosuppressants, antidiabetic agents, cardiovascular disorders |
| 01/15/2004 | US20040010147 Cyclic amine compounds and pharmaceutical composition containing the same |
| 01/15/2004 | US20040010139 Using iridium complex as hydrogenation catalyst |
| 01/15/2004 | US20040010033 N-cyclohexylmethyl- or N-benzyl-5-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphth-2-yl)furan-2 -carboxamide derivatives; suppression of gonadotropin release to treat hormone dependant tumors and reproductive disorders |
| 01/15/2004 | US20040010030 Novel anti-infectives |
| 01/15/2004 | US20040010029 Also benzothiophene derivatives; treating allergy, asthma, rhinitis, dermatitis, B-cell lymphomas, tumors and infections; modulating T helper cells, Th1/ Th2, and inhibiting the transcription of IL-4 |
| 01/15/2004 | US20040010027 Tumor angiogenesis and metastasis inhibition. |
| 01/15/2004 | US20040010019 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 01/15/2004 | US20040010013 Cannabinoid receptor ligands |
| 01/15/2004 | US20040010011 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |